Bevin Carter, founder of Mercer Carter Consulting, is proud to announce a strategic partnership with Prosetta Biosciences, a pioneering biotechnology company at the forefront of oncology innovation. Bevin Carter and Vishwanath R. Lingappa, CEO of Prosetta Biosciences, together aim to accelerate progress in the fight against cancer with transformative treatments.
Bevin’s journey into cancer research started with her mother’s battle with breast cancer, similar to Reed Jobs’ inspiration from his father, the late Apple co-founder’s fight against pancreatic cancer. This personal connection led Reed to establish Yosemite, a $200 million venture fund for cancer and biotech research. Both Bevin and Reed, deeply influenced by personal experiences, become influential voices in the fight against cancer.
Prosetta’s groundbreaking research in identifying oncology-active compounds with broad pan-cancer efficacy marks a significant breakthrough. The comprehensive evaluation of these compounds across various cancer types promises to revolutionize oncology treatment.
That’s why Bevin’s teaming up with Prosetta Biosciences is a really important step in oncology research. In one of the meetings expressing her motivation, Bevin was quoted saying, “I’m doing this because the world has no time,” which encapsulates her sense of commitment to driving positive change in the fight against cancer.
Bevin’s holistic perspective recognizes the interconnectedness of all aspects of life, including the environment in which cancer patients receive treatment. By integrating holistic principles into cancer research and treatment, Bevin aims to create a nurturing and supportive environment that promotes healing and well-being on multiple levels.
Through her collaboration with Prosetta Biosciences, Bevin is driving a paradigm shift in oncology research towards a more holistic and patient-centered approach. It will prioritize the well-being of patients and the environment alike and pave the way for a future where cancer, Parkinson’s, and Alzheimer’s treatment will be effective and conducive to holistic healing and environmental sustainability.
About Prosetta Biosciences
Prosetta Biosciences, a dynamic biotechnology company headquartered in San Francisco, is dedicated to driving innovation in disease therapeutics. Prosetta Biosciences aims to develop therapeutics that treat diseases, from cancer to neurodegenerative disorders – Parkinson’s and Alzheimer’s.
About Bevin Carter
Bevin Carter, founder of Mercer Carter Consulting, is a wellness professional, former scientist, and creative interior designer. Carter has a profound connection between body, mind, and spirit. She empowers individuals and organizations to unlock the transformative power of holistic living. By integrating principles of holistic wellness into the research and development process, Carter and Prosetta Biosciences are able to explore innovative approaches to cancer treatment that prioritize the well-being of patients on a holistic level.
Take the first step towards understanding cancer research and embracing a holistic approach! Visit https://mercercarter.com/ or https://prosetta.com/ for more information!
